Market Value1,635,018,721
Total Holdings63
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
JAZZ / Jazz Pharmaceuticals plc
BSX / Boston Scientific Corporation
AXSM / Axsome Therapeutics, Inc.
ELVN / Enliven Therapeutics, Inc.
PEN / Penumbra, Inc.
MTSR / Metsera, Inc.
APGE / Apogee Therapeutics, Inc.
SVRA / Savara Inc.
VERA / Vera Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
INSM / Insmed Incorporated
SUPN / Supernus Pharmaceuticals, Inc.
IBB / iShares Trust - iShares Biotechnology ETF Put
PRAX / Praxis Precision Medicines, Inc.
SLNO / Soleno Therapeutics, Inc.
AVBP / ArriVent BioPharma, Inc.
JBIO / Jade Biosciences, Inc.
IMNM / Immunome, Inc.
DXCM / DexCom, Inc.
DYN / Dyne Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
IDYA / IDEAYA Biosciences, Inc.
IMTX / Immatics N.V.
RAPP / Rapport Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
PHVS / Pharvaris N.V.
SYK / Stryker Corporation
COGT / Cogent Biosciences, Inc. Call
COGT / Cogent Biosciences, Inc.
ACAD / ACADIA Pharmaceuticals Inc. Call
BMY / Bristol-Myers Squibb Company
INBX / Inhibrx Biosciences, Inc.
BIOA / BioAge Labs, Inc.
EWTX / Edgewise Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
QURE / uniQure N.V.
ABBV / AbbVie Inc.
RCUS / Arcus Biosciences, Inc.
ANAB / AnaptysBio, Inc.
UTHR / United Therapeutics Corporation
RYTM / Rhythm Pharmaceuticals, Inc.
RYTM / Rhythm Pharmaceuticals, Inc. Put
IWM / iShares Trust - iShares Russell 2000 ETF Put
QQQ / Invesco QQQ Trust, Series 1 Put
SMMT / Summit Therapeutics Inc. Call
PTCT / PTC Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
MDT / Medtronic plc
KURA / Kura Oncology, Inc.
ERAS / Erasca, Inc.
BPMC / Blueprint Medicines Corporation
INCY / Incyte Corporation
VIR / Vir Biotechnology, Inc.
DHR / Danaher Corporation
BOLT / Bolt Biotherapeutics, Inc.
MRUS / Merus N.V.
IKNA / Ikena Oncology, Inc.
INZY / Inozyme Pharma, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
CDTX / Cidara Therapeutics, Inc.
RNA / Atrium Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc. Put
CDTX / Cidara Therapeutics, Inc. Call
SLNO / Soleno Therapeutics, Inc. Put
NTRA / Natera, Inc.
SRRK / Scholar Rock Holding Corporation
NXTC / NextCure, Inc.
GILD / Gilead Sciences, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
EXAS / Exact Sciences Corporation
YMAB / Y-mAbs Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
REPL / Replimune Group, Inc.
REPL / Replimune Group, Inc. Put
ROIV / Roivant Sciences Ltd. Call
IRON / Disc Medicine, Inc.
ROIV / Roivant Sciences Ltd.
LLY / Eli Lilly and Company
ISRG / Intuitive Surgical, Inc.